The S&P 500 is more top-heavy today than at any point since the Nifty Fifty era — and JPMorgan says artificial intelligence is the force pulling the market apart. They estimate that just 30 AI-linked stocks now account for roughly…
Oracle Corp. (NYSE:ORCL) is facing mounting investor scrutiny just months after a major leadership change, as concerns grow over the company's aggressive push into artificial intelligence infrastructure. Shares of the software giant have fallen about 30% this quarter, reflecting skepticism…
While Wall Street traded in a subdued session marked by thin liquidity and low volumes following the Christmas market closure, price action turned wild across precious and industrial metals. By midday trading in New York, silver prices — as tracked…
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) stock rose Friday, even as the company disclosed no new announcements to explain the move. The stock action follows a corporate update earlier this week outlining progress in the company’s Phase 3 FLAMINGO-01 clinical trial and…
XPeng Inc. (NYSE:XPEV) shares rose Friday after the Chinese electric vehicle maker unveiled new expansion plans in the Middle East and Africa. The Chinese EV maker said that it held a brand launch event in Doha, Qatar, introducing new SUVs…
On Friday, Gravity Co., Ltd. (NASDAQ:GRVY) said its 3D mobile MMORPG Ragnarok: Rebirth officially launched in China on Dec. 25, 2025, marking a key expansion in one of the world’s largest gaming markets. The company said the title retains the…
China on Friday imposed sanctions on 20 U.S. defense companies and 10 executives, escalating tensions with Washington over Taiwan and deepening the broader U.S.-China strategic rivalry. The measures target firms including Northrop Grumman Corp. (NYSE:NOC), L3Harris Technologies, Inc.’s (NYSE:LHX), Maritime…
ECD Auto Design Inc. (NASDAQ:ECDA) announced on Friday a major expansion of its 2026 product lineup, encompassing heritage-inspired coupes, classic SUVs, and modern lifestyle 4x4s. The company said the expanded roadmap introduces new model families, deeper engineering refinement, and broader…
On Friday, Johnson & Johnson (NYSE:JNJ) shared the planned interim analysis from Phase 2b DUPLEX-AD proof-of-concept study of JNJ-95475939 for moderate to severe atopic dermatitis (AD). Atopic dermatitis or eczema is a chronic skin condition causing dry, intensely itchy, inflamed,…
Animal health firm ImmuCell Corporation (NASDAQ:ICCC) received an Incomplete Letter from the United States Food and Drug Administration (FDA) on Tuesday for its Re-Tain New Animal Drug Application (NADA). Re-Tain is the company’s intramammary treatment for subclinical mastitis in lactating…